U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H6N3O4P.2Na
Molecular Weight 237.0614
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSFOCREATININE DISODIUM

SMILES

[Na+].[Na+].CN1CC(=O)N=C1NP([O-])([O-])=O

InChI

InChIKey=SXKIJBYZZDVCOF-UHFFFAOYSA-L
InChI=1S/C4H8N3O4P.2Na/c1-7-2-3(8)5-4(7)6-12(9,10)11;;/h2H2,1H3,(H3,5,6,8,9,10,11);;/q;2*+1/p-2

HIDE SMILES / InChI

Molecular Formula C4H6N3O4P
Molecular Weight 191.0819
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Fosfocreatinine, a cardioprotectant that was used for the treatment of cardiac disorders. Information about the current use of this drug is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
High-energy phosphate metabolism in the calf muscle during moderate isotonic exercise under different degrees of cuff compression: a phosphorus 31 magnetic resonance spectroscopy study.
2005 Aug
Phosphorous-31 magnetic resonance spectroscopy of cervical cancer using transvaginal surface coil.
2005 Dec 31
A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
2006 Feb
Effect of neuronal nitric oxide synthase inhibition on caspase-9 activity during hypoxia in the cerebral cortex of newborn piglets.
2006 Jun 19
Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction.
2006 Mar 31
A novel relationship between creatine transport at the blood-brain and blood-retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis.
2007
Evidence of brain mitochondrial activities after oxygen inhalation by 31P magnetic resonance spectroscopy at 3T.
2007
Phosphorylation potential in the dominant leg is lower, and [ADPfree] is higher in calf muscles at rest in endurance athletes than in sprinters and in untrained subjects.
2007 Dec
Conditions of wound healing and cutaneous growth affect metabolic performance of skin following plastic surgery.
2007 Jul-Aug
Effect of hypoxia on the expression of procaspase-9 and procaspase-3 in neuronal nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets.
2008 Jun 13
Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders.
2009
Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy.
2009 Aug
Replication independent formation of extrachromosomal circular DNA in mammalian cell-free system.
2009 Jul 1
Pathogenesis of insulin resistance in skeletal muscle.
2010
Slope-based stochastic resonance: how noise enables phasic neurons to encode slow signals.
2010 Jun 24
Asymmetric excitatory synaptic dynamics underlie interaural time difference processing in the auditory system.
2010 Jun 29
Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy.
2010 Sep
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:02:02 UTC 2023
Edited
by admin
on Fri Dec 15 19:02:02 UTC 2023
Record UNII
I3XPR4LFWY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FOSFOCREATININE DISODIUM
WHO-DD  
Common Name English
Fosfocreatinine disodium [WHO-DD]
Common Name English
SUSTENIUM
Brand Name English
CREATERGYL
Brand Name English
PHOSPHORAMIDIC ACID, (1-METHYL-4-OXO-2-IMIDAZOLIDINYLIDENE)-, DISODIUM SALT
Common Name English
PHOSPHOCREATININE SODIUM SALT
Common Name English
ERGADYL
Brand Name English
DORAXO
Brand Name English
PHOSPHORAMIDIC ACID, (4,5-DIHYDRO-1-METHYL-4-OXO-1H-IMIDAZOL-2-YL)-, DISODIUM SALT
Common Name English
Code System Code Type Description
PUBCHEM
101321352
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
FDA UNII
I3XPR4LFWY
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
EVMPD
SUB02260MIG
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
ECHA (EC/EINECS)
243-181-3
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
SMS_ID
100000086999
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
CAS
19604-05-8
Created by admin on Fri Dec 15 19:02:02 UTC 2023 , Edited by admin on Fri Dec 15 19:02:02 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE